Pomerantz Appointed Lead Counsel in AcelRx Pharmaceuticals Securities Litigation

On December 16, 2021, U.S. District Judge Beth Labson Freeman, of the Northern District of California – San Jose Division, appointed Pomerantz LLP as Lead Counsel on behalf of Aaron Sneed and Yaacov Musry, the Lead Plaintiffs in Sneed Jr. v. AcelRx Pharmaceuticals, Inc. et al, 21-cv-4353 (N.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that AcelRx Pharmaceuticals, Inc. made false or misleading claims and representations in marketing materials about the risks and efficacy of DSUVIA, its lead product candidate for the treatment of moderate-to-severe…